These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 34043963)
1. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study. Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Garland SM; Cornall AM; Atchison S; Hocking JS; Bradshaw CS; Balgovind P; Murray GL; Chen MY Lancet Infect Dis; 2021 Oct; 21(10):1448-1457. PubMed ID: 34043963 [TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus Antibody Levels Following Vaccination or Natural Infection Among Young Men Who Have Sex With Men. Chow EPF; Fairley CK; Zou H; Wigan R; Garland SM; Cornall AM; Atchison S; Tabrizi SN; Chen MY Clin Infect Dis; 2022 Aug; 75(2):323-329. PubMed ID: 34971362 [TBL] [Abstract][Full Text] [Related]
3. Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study. Zou H; Tabrizi SN; Grulich AE; Hocking JS; Bradshaw CS; Cornall AM; Morrow A; Prestage G; Law MG; Garland SM; Chen MY; Fairley CK Lancet Infect Dis; 2015 Jan; 15(1):65-73. PubMed ID: 25435055 [TBL] [Abstract][Full Text] [Related]
4. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Liu B; Bateson D; McNamee K; Garefalakis M; Phillips S; Cummins E; Malloy M; Garland SM Lancet Infect Dis; 2014 Oct; 14(10):958-66. PubMed ID: 25107680 [TBL] [Abstract][Full Text] [Related]
5. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study. Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422 [TBL] [Abstract][Full Text] [Related]
6. Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination. Zhou Y; Lin YF; Meng X; Duan Q; Wang Z; Yang B; Zheng H; Li P; Li M; Lu Y; Luo Z; Zou H Vaccine; 2020 Mar; 38(13):2849-2858. PubMed ID: 32088017 [TBL] [Abstract][Full Text] [Related]
7. HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination. Woestenberg PJ; van Benthem BHB; Bogaards JA; King AJ; van der Klis FRM; Pasmans H; Leussink S; van der Sande MAB; Hoebe CJPA; Vaccine; 2020 Apr; 38(17):3321-3329. PubMed ID: 32201140 [TBL] [Abstract][Full Text] [Related]
8. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705 [TBL] [Abstract][Full Text] [Related]
9. Anal human papillomavirus infections in young unvaccinated men who have sex with men attending a sexual health clinic for HPV vaccination in Melbourne, Australia. Chow EPF; Danielewski JA; Murray GL; Fehler G; Chen MY; Bradshaw CS; Garland SM; Fairley CK Vaccine; 2019 Oct; 37(43):6271-6275. PubMed ID: 31521414 [TBL] [Abstract][Full Text] [Related]
10. Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men-United States, 2016-2018. Meites E; Winer RL; Newcomb ME; Gorbach PM; Querec TD; Rudd J; Collins T; Lin J; Moore J; Remble T; Swanson F; Franz J; Bolan RK; Golden MR; Mustanski B; Crosby RA; Unger ER; Markowitz LE J Infect Dis; 2020 Nov; 222(12):2052-2060. PubMed ID: 32504091 [TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies. King EM; Gilson R; Beddows S; Soldan K; Panwar K; Young C; Prah P; Jit M; Edmunds WJ; Sonnenberg P Br J Cancer; 2015 Apr; 112(9):1585-93. PubMed ID: 25791874 [TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus. Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185 [TBL] [Abstract][Full Text] [Related]
13. Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014. Meites E; Gorbach PM; Gratzer B; Panicker G; Steinau M; Collins T; Parrish A; Randel C; McGrath M; Carrasco S; Moore J; Zaidi A; Braxton J; Kerndt PR; Unger ER; Crosby RA; Markowitz LE J Infect Dis; 2016 Sep; 214(5):689-96. PubMed ID: 27296847 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender Women. Winer RL; Lin J; Querec TD; Unger ER; Stern JE; Rudd JM; Golden MR; Swanson F; Markowitz LE; Meites E J Infect Dis; 2022 Feb; 225(3):422-430. PubMed ID: 34320185 [TBL] [Abstract][Full Text] [Related]
15. Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach. Bogaards JA; Mooij SH; Xiridou M; Schim van der Loeff MF PLoS Med; 2019 Mar; 16(3):e1002756. PubMed ID: 30830901 [TBL] [Abstract][Full Text] [Related]
16. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program. Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN; Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506 [TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study. Chow EP; Danielewski JA; Fehler G; Tabrizi SN; Law MG; Bradshaw CS; Garland SM; Chen MY; Fairley CK Lancet Infect Dis; 2015 Nov; 15(11):1314-23. PubMed ID: 26201300 [TBL] [Abstract][Full Text] [Related]
18. Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials. Mariz FC; Gray P; Bender N; Eriksson T; Kann H; Apter D; Paavonen J; Pajunen E; Prager KM; Sehr P; Surcel HM; Waterboer T; Müller M; Pawlita M; Lehtinen M Lancet Infect Dis; 2021 Oct; 21(10):1458-1468. PubMed ID: 34081923 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017. Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Regan DG; Hocking JS; Garland SM; Cornall AM; Atchison S; Bradshaw CS; McNulty A; Owen L; Marshall L; Russell DB; Kaldor JM; Chen MY Vaccine; 2019 Oct; 37(46):6907-6914. PubMed ID: 31562001 [TBL] [Abstract][Full Text] [Related]
20. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men. Videla S; Darwich L; Cañadas MP; Coll J; Piñol M; García-Cuyás F; Molina-Lopez RA; Cobarsi P; Clotet B; Sirera G; Sex Transm Dis; 2013 Jan; 40(1):3-10. PubMed ID: 23250297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]